Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TheraSphere Japan Pre-Market Study — Stella

Home/Liver Neoplasms/TheraSphere Japan Pre-Market Study

View on ClinicalTrials.gov

Recruiting

Back to Liver Neoplasms trials

TheraSphere Japan Pre-Market Study

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

Japan

Hyogo College of Medicine Hospital, Nishinomiya, Hyōgo

Kanazawa University Hospital, Kanazawa, Ishikawa-ken

Kindai University Hospital, Sayama, Osaka

National Cancer Center Hospital, Chuo Ku, Tokyo

Key details

Sponsor

Boston Scientific Corporation

Enrollment target

~51 participants

Started

January 2026

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.